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In the thymus, dendritic cells (DC) are functionally associated with thymocytes and are recognized to play a major role
in the intrathymic differentiation of T cells. Several studies have previously investigated the role of DC during HIV-infection,
but the status of thymic DC in HIV-1 pathogenesis remains unclear. In this study, we investigated the susceptibility of
purified human thymic DC to HIV-1 infection in vitro. HIV-1 was not detected in cell-free supernatants collected from HIV-
infected DC. However, these cultures were shown to transmit HIV-1 infection since coculture with permissive MT4 cells
resulted in virus production. The exposure of DC in culture to HIV-1 was shown to promote severe DC morphological
changes and killing. We also found that one or several heat labile soluble cytotoxic agents present in the HIV-1-infected
DC supernatant mediated the killing of thymocytes. Our observations raise the possibility that (1) the HIV-1-induced DC
killing, (2) the capacity of DC to transmit viral infection, and/or (3) the release of HIV-1-mediated cytotoxic agent(s) from
DC may contribute to AIDS pathogenesis in vivo. q 1996 Academic Press, Inc.
INTRODUCTION with involution and disruption of normal architecture have
been noted at necropsy in patients dying with AIDS (Joshi
Clinical and immunological manifestations of AIDS are et al., 1986; 1990; Nezelof, 1992; Mano and Chermann,
known to be associated with HIV infection. The most 1991). In addition, HIV infection of severe combined im-
consistent and striking observation of HIV infection is a munodeficiency (SCID) mice implanted with human thy-
progressive depletion of CD4/ T cells (Klatzmann et al., mic tissue resulted in marked depletion of thymocytes,
1984). The dysfunction and quantitative depletion of productive infection, and destruction of stromal elements
CD4/ T cells have been proposed to occur by a wide (Aldrovandi et al., 1993; Bonyhadi et al., 1993; Stanley et
range of distinct direct and/or indirect mechanisms (as al., 1993). These observations suggested a possible role
reviewed in Levy, 1993). Recently, a simple steady-state of the thymus in the pathophysiology of AIDS. Thymo-
model has been proposed in which infection, cell death, cytes at different stages of cell maturation and non-
and cell replacement are in balance during the period lymphoid cells have been previously shown to be sus-
prior to the onset of AIDS (Coffin, 1995; Ho et al., 1995; ceptible to HIV infection both in in vitro cell cultures and
Wei et al., 1995). This suggests that an imbalance of such in vivo using SCID mice reconstituted with human thymus
a dynamic process, either by an increase of CD4/ T cell (Stanley et al., 1993; Tremblay et al., 1990; De Rossi et
mortality or a decrease in CD4/ T cell replenishment, al., 1990; Schnittman et al., 1990; Valentin et al., 1994;
could result in a decrease of the CD4/ T cell population. Sandborg et al., 1994). One of the nonlymphoid cells
Recent findings support rather the view that AIDS is pri- targeted by HIV has been proposed to be thymic dendritic
marily a consequence of continuous rapid high-level rep- cells (DC) (Valentin et al., 1994; Mu¨ller et al., 1993). DC
lication of HIV-1 leading to virus- and immune-mediated represent a family of cells which are found in small num-
killing of CD4/ lymphocytes. However, indirect mecha- bers in nonlymphoid and lymphoid tissues (Steinman,
nisms leading to a decrease in the level of CD4/ mature 1991). DC express a high level of MHC class II molecules
T cell replenishment might influence the period of HIV- and are recognized to be potent APC for a variety of
related disease prior to the onset of AIDS. T cell-dependent immune responses (Steinman, 1991;
The human thymus is an active organ that plays a key Bjercke et al., 1985). Human thymic DC are marrow-de-
role in the maturation, differentiation, and function of the rived leukocytes which are intimately associated with
T cell immune system (Ritter and Boyd, 1993). The pres- thymocytes (Landry et al., 1989). The involvement of DC
ence of HIV infection and severe thymic abnormalities in thymocyte maturation is generally accepted, although
their precise influence is still being debated.
DC from several tissues have been analyzed for in vivo1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (514) 343-5995. E-mail: cohenea@ere.umontreal.ca. and in vitro susceptibility to HIV-1 infection (review in
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Cameron et al., 1996). To date, it is not yet clear whether gradient. Cells were then further enriched by negative
depletion using a cocktail of unconjugated monoclonalDC can support fully productive replication of HIV-1 be-
cause of conflicting data. Apparent contradictory results antibodies containing anti-CD2, -CD3, -CD5, -CD7, -CD8,
and -CD14. Reactive cells were fixed to magnetic beadsseem to depend upon the composition of the cell popula-
tion studied which differ according to the method of puri- and removed using a magnetic separator. Purified den-
dritic cell were maintained at 2 1 106 cells/ml in RPMIfication or to whether in vivo populations were analyzed.
Productive HIV-1 infection was demonstrated in skin DC 1640 medium supplemented with 10% FCS, 100 U/ml
penicillin, and 100 mg/ml streptomycin, 25 mM HEPES,in in vivo studies (Langerhans cells (LC)) (as reviewed
in Dezutter-Dambuyant and Schmitt, 1994). Similarly, re- 4 mM glutamine, 10 mM 2-mercaptoethanol, and 2 mM
sodium pyruvate and incubated at 377 in a 5% CO2 atmo-sults from in vitro experiments demonstrate that produc-
tive HIV-1 infection was also observed in conjugates of sphere. This purification method allows the reproducible
recovery of cell populations as characterized in Table 1.DC and T cells derived from normal skin but not in puri-
fied LC largely free of T cells (Pope et al., 1994). Results Unfractionated thymic cell populations were maintained
at high concentration in the same medium at 47 beforefrom in vitro studies have demonstrated that blood DC
can be readily infected by HIV-1 (Patterson et al., 1991; the assays.
Langhoff et al., 1991), whereas a recent study suggests
Virus stock and HIV-1 infectionthat blood DC, like LC, do not sustain productive infec-
tion, but rather transmit cytopathic infection to stimulated
Stocks of the T tropic HIV-1 IIIB strain were produced
T cells (Cameron et al., 1992).
from the UHC-1 cell line (gift of Dr. M. Wainberg, Lady
To assess the role of thymic DC in HIV-1 pathogene-
Davis Institute for Medical Research, Montre´al, Que´bec).
sis, we studied the susceptibility of purified human
A stock of the macrophage tropic HIV-1 BaL strain was
thymic DC to HIV-1 infection in vitro. We report here
produced by transfecting Cos-7 cells with pIIIB-BaL (gift
that HIV-1 infection of highly purified thymic DC does
of Dr. Bryan Cullen, Durham, NC; Hwang et al., 1991).
not lead to the release of detectable viral particles in
Each viral stock was obtained from concentrated cell-
culture supernatant. However, the infected DC cultures
free culture supernatants filtered through a 0.22-mm sy-
were found to be associated with fully infectious viral
ringe-loaded filter unit (Costar, Cambridge, MA) and ti-
particles even in long-term cultures and to exhibit pro-
trated by end-point dilution using the MT4 cell line (IIIB)
found cell morphological changes and mortality. In ad-
or by measurement of reverse transcriptase (RT) activity
dition, we show that HIV-1-infected DC failed to pro-
(BaL). HIV-1 (IIIB) viral stocks were heated at 587 for 50
mote thymocyte stimulation. Our results demonstrate
min for assays using heat-inactivated virus (Harada et
that this phenomenon is mediated by one or several
al., 1985). Lack of infectivity of the heat-inactivated virus
soluble thymocyte killing factor(s) released in the su-
was tested on HIV-sensitive CD4/ MT4 cells.
pernatant from HIV-1-infected DC.
As indicated, freshly purified DC and unfractionated
thymic cells were mock-infected or infected with viral
MATERIALS AND METHODS
stocks at m.o.i. of 0.1 TCID50/cell (IIIB) or on the basis of
identical RT activity (BaL). After an adsorption period ofCell lines and preparation of purified thymic dendritic
4 to 6 hr at 377, in a 5% CO2 atmosphere, cells werecells
extensively washed with PBS to remove nonadherent vi-
UHC-1, a promonocytic cell line chronically infected
ruses. Infected or mock-infected DC and unfractionated
with the IIIB strain of HIV-1 (Boulerice et al., 1990) and
thymic cells were then resuspended at 2 1 106 cells/
MT4, a human T-lymphotropic virus type-1 (HTLV-I)-trans-
ml in supplemented RPMI 1640 containing 10% filtered
formed T-lymphoid cell line (Harada et al., 1985), were
supernatant collected from a 48-hr PHA-stimulated PBL
kept in RPMI 1640 medium (Gibco, Grand Island, NY)
culture. Cell suspensions were subsequently distributed
supplemented with 10% heat-inactivated FCS. Cos-7, an
in 24-well cell culture plates (1 ml/well) (Falcon, Lincoln
African green monkey kidney cell line transformed by an
Park, New Jersey) or in 15-ml tubes for the following
origin-defective mutant of simian virus 40 (Gluzman,
assays.
1981) was maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FCS. Cells Detection of viral particles
were incubated at 377 in a 5% CO2 humidified atmo-
sphere. To detect viral particle production, cell supernatants
were tested for the presence of reverse transcriptaseDendritic cells were isolated according to the Double
Step purification method described previously (Beaulieu (RT) activity and p24 (capsid antigen) as follows. Two-
hundred fifty microliters of supernatants from triplicateet al., 1995). Briefly, unfractionated human thymic cells
were first depleted of CD2/ reacting thymocytes by incu- cultures of DC or unfractionated thymic cells were col-
lected each day and replaced with fresh medium. Virus-bation with neuraminidase-treated sheep red blood cells
followed by a Ficoll separation. The remaining cells were specific RT activity in each supernatant was measured
as described (Lee et al., 1987). Release of capsid anti-separated according to their density on a 50% Percoll
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gens was determined by detection of p24 in the culture anhydride as described. They were then hybridized over-
night at 557 with 35S-labeled sense or antisense RNAsupernatant, using an enzyme-linked immunosorbent
assay kit (ELISA HIVAG-1, Abbott Laboratories, Abbott probes transcribed from the plasmid pGEM3-vpu which
harbors the HIV-1-specific vpu gene under the control ofPark, IL). The sensitivity of the assay is 1–2 pg/ml.
In reinfection assays, 250 ml of supernatant was col- the Sp6 and T7 phage RNA polymerase promoter (Terwil-
liger et al., 1989). The anti-sense probe used allows de-lected, centrifuged at 3000 rpm, and filtered. At Days 2,
4, 6, 7, and 11 the filtered supernatants were added to tection of unspliced and singly spliced viral RNAs. The
hybridization mixture (20 ml/slide) consisted of 50% for-2 1 105 MT4 cells/ml cultured in 24-well plates. In cocul-
ture assays, 2 1 105 MT4 were directly added to nonin- mamide, 0.6 M NaCl, 11 Denhart solution, 10 mM Tris–
HCl (pH 8), 1 mM EDTA, 10% Dextran sulfate, 0.5 mg/fected or to infected-DC at Days 2, 6, and 12 following
in vitro culture on 24-well plates. Viral replication was ml tRNA, 100 mg/ml poly(A) RNA, 1 mg/ml BSA, 10 mM
dithiotreitol, 10 mg/ml salmon sperm DNA, and the equiv-examined for up to 28 days according to the following
procedures; 250 ml of supernatant from triplicate cultures alent of 5 1 105 cpm of the labeled probes. After hybrid-
ization, the slides were rinsed several times in a bufferwere collected each day and replaced with fresh me-
dium. MT4 infection was monitored by measurement of containing 10 mM Tris (pH 8), 1 mM EDTA, 0.6 M NaCl,
and 50% formamide at 557 followed by several washes atRT activity and p24 in each supernatant as well as for
the presence of syncytium formation. room temperature in the same buffer without formamide.
Finally, the slides were rinsed in 1 SSC (0.15 M NaCl,
Cell survival kinetics 0.015 M sodium citrate), dehydrated, and covered with
NTB2 Kodak nuclear emulsion. After a 10- to 14-day expo-Cell viability was monitored daily in uninfected DC,
sure, the slides were developed in D19 developer (Ko-unfractionated thymic cells, or in DC infected with either
dak) and fixed in 30% sodium thiosulfate. The specificlive or heat-inactivated HIV-1 virus by trypan blue exclu-
signal was evaluated by quantifying the number of silversion assay. Cell viability was also monitored in 24-hr
grains associated to the cells and subtracting the back-uninfected DC or in unfractionated thymic cells treated
ground labeling.with filtered supernatants collected from autologous un-
Immunocytochemistry reactions to detect the pres-infected or infected DC at Day 1 or from allogenic unin-
ence of HLA-DR antigens were performed on similar cy-fected or infected DC at Day 6.
tospin cell preparations that were fixed in cold acetone
for 30 min. Slides were treated with 0.3% hydrogen perox-FACS analysis of infected and uninfected dendritic
ide in PBS to block endogenous peroxidase activity forcells
30 min. Cells were subsequently washed twice in PBS
Phenotypic analysis of uninfected and infected DC was and incubated at room temperature with a saturating
determined by direct or indirect immunofluorescence amount of HLA-DR mAb for 30 min. Samples were
with anti-CD1, -CD2, -CD3, -CD4, -CD5, -CD7, -CD8, washed three times in PBS, incubated with biotinylated
-CD11b, -CD14, -CD20, -HLA-DR monoclonal antibodies goat anti-mouse IgG (H / L) (Caltag Laboratories, San
(mAbs) (Becton Dickinson, Mountain View, CA; Coulter Francisco, CA) at 1:500 for 30 min, washed in PBS, and
Immunology, Hialeah, FL; and Ortho Diagnostic, Raritan, incubated with peroxidase-conjugated streptavidin
NJ) as described (Beaulieu et al., 1995). Briefly, 2 1 105 1:1000 for 30 min. The reaction was revealed with 0.05%
cells were incubated on ice for 1 hr with a saturating diaminobenzidine (DAB) and 0.01% hydrogen peroxide in
amount of the appropriate mouse anti-human mAb. The a 0.05 M Tris buffer, pH 7.6. In control samples, cells
cells were subsequently incubated on ice during 30 min were treated in a similar fashion but in the absence of
with a saturating amount of FITC-conjugated goat anti- primary antibody. Cells were counter stained with hema-
mouse IgG (Gibco/BRL). MAb-reactive cell distribution toxylin, mounted in Permount, and examined with a Zeiss
was analyzed using a FACStar at Days 0 and 2 following microscope.
purification (Becton Dickinson, Mountain View, CA) with
Electron microscopy analysisthe Consort 30 program.
Transmission electron microscopy (EM) was per-
In situ hybridization analysis
formed on 10 1 106 cells as described in Beaulieu et al.
(1995). Briefly, infected or uninfected cells were fixed withThe cell pretreatment and in situ hybridization (ISH)
were performed as described (Haase et al., 1984; Cox 2.5% glutaraldehyde in Sorensen buffer (0.1 M sodium
phosphate, pH 7.2) for 1 hr at 47. After washing withet al., 1984) with minor modifications. Briefly, infected
and uninfected DC samples were centrifuged and the Sorensen buffer, cells were postfixed in 2% osmium te-
troxide before dehydration in graded ethanol and embed-cell pellets were rinsed and resuspended in PBS buffer.
Duplicate samples made of 21 105 cells were cytocentri- ded in Epon (JBEM Services, Pointe-Claire, Dorval, Can-
ada). Ultrathin sections were stained with lead Reynoldfuged at 400 rpm for 5 min in a Cytospin. The cells were
fixed in a mixture of methanol/acetic acid (3:1) for 15 min and uranyl acetate (Fisher). Cells were examined with a
Philips EM-300 electron microscope.at 47, dried, and pretreated with proteinase K and acetic
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TABLE 1Statistical analysis
Phenotypic Characterization of HIV-1-Infected and Uninfected DCStatistical analyses for ISH and EM were performed
Populations
on data obtained from, respectively, two and three inde-
pendent experiments. We have used the z-test for com- Percentage of positive cellsa
paring two proportions and have calculated the associ-
Uninfected DCb DC / HIV-1cated P value to evaluate the statistical significance
(Moore and McCabe, 1993).
mAb Day 0 Day 2 Day 0 Day 2
Accessory function assay CD 1 2.92 7.31 2.85 5.22
CD 2 2.14 0.66 1.09 0.49
The ability of uninfected or infected DC to induce thy- CD 3 0.87 0.48 0.50 0.46
CD 4 16.8 12.6 12.3 10.3mocyte proliferation was performed as described in
CD 5 8.39 2.66 6.08 1.88Beaulieu et al. (1995). Briefly, total autologous thymic
CD 7 5.39 1.82 3.19 0.98cells were incubated with or without graded doses of
CD 8 0.27 0.32 0.24 0.15
concanavalin A (Con A) (St. Louis, MO) ranging from 0.5 CD 11b 2.75 0.46 2.03 0.33
to 10 mg/ml during 72 hr at 377 in the presence or ab- CD 14 0.46 0.23 0.35 0.22
CD 20 0.35 ND 0.31 NDsence of 24-hr-cultured purified thymic DC at a 10:1 cell
HLA-DR 88.6 80.0 77.7 75.2ratio (3 1 105 autologous thymic cells for 3 1 104 purified
DC per well) in a 96-well round-bottomed microtiter plate a Phenotypic analysis was performed by flow cytometric analysis as
(Linbro, Flow Laboratories). DNA synthesis was moni- described in Beaulieu et al. (1995). The results correspond to mean
tored by directly adding 0.5 mCi [3H]thymidine-methyl (6.7 values from three independent experiments. ND, not determined.
b Analysis was performed on DC populations at Days 0 and 2 follow-Ci/mmol, Du Pont Canada Inc., NEN Products, Montre´al,
ing DC purification.Canada) to the culture for 18 hr. Cells were harvested
c Freshly purified cells were infected with HIV-1 (IIIB) and submittedon glass fiber filters (Skatron Titerteck Cell Harvester)
to FACS analysis after the adsorption period (Day 0) or at Day 2 postin-
and the level of cellular [3H]thymidine-methyl incorpora- fection.
tion was evaluated in the presence of scintillation liquid
Econofluor-2 (Du Pont Canada Inc.) in a scintillation
thymic cells exhibited viral production that reached acounter (Beckman LS-600 SC). Each sample was per-
maximum at Day 4 postinfection (results not shown).formed in triplicate. As indicated, 24-hr cultured DC were
In order to determine if infectious viral particles werealso incubated 24 hr prior to the accessory function
present in cell supernatants, we exposed the highly HIV-assays with filtered cell culture supernatants collected
1-sensitive cell line, MT4, to cell-free supernatants col-at Day 1 after infection and/or purification from autolo-
lected at Days 2, 4, 6, 7, and 11 from uninfected, HIV-1gous DC.
(IIIB strain), or heat-inactivated HIV-1-infected DC. MT4
cells were monitored daily for cytopathic effects and RT
RESULTS activity, as well as for the presence of p24 antigen in cell
supernatants. Viral replication was not detected in MT4Evaluation of viral production in HIV-infected DC
cells infected with any culture supernatant up to 28 dayspopulation
(data not shown). These results indicate that infectious
viral particles were not detectable in the supernatantUnfractionated thymic cells or populations of freshly
purified human thymic DC containing more than 80% of fluids of HIV-1-infected DC populations.
To determine whether HIV-infected DC could transmitCD20/HLA-DR/ cells were infected either with laboratory
HIV-1 isolates (IIIB or BaL strains) or with heat-inacti- infection, we added HIV susceptible MT4 cells to DC
populations at 2, 6, or 12 days postinfection with live orvated HIV-1 (IIIB) in order to evaluate the susceptibility
of cells to HIV-1 infection. The cytofluorometric analysis heat-inactivated HIV-1 (IIIB). RT activity in the superna-
tants was measured everyday or every 2 days. Viral repli-of DC at Days 0 and 2 following infection and/or purifica-
tion are described in Table 1. No significant difference cation was detectable since MT4 cells, in coculture with
HIV-1-infected DC, exhibited typical syncytium formationwas observed in the distribution of mAb reactive cells
between uninfected and infected DC even after 2 days (data not shown), and RT activity was present in the
supernatant (Fig. 1). In contrast, viral replication was notof culture. During the culture period, ranging from Days
0 to 11, supernatants were collected daily from unin- observed in MT4 cells cocultured with heat-inactivated
HIV-1-infected DC (data not shown). Maximum RT activityfected or infected DC populations and analyzed for the
presence of RT activity and p24 Gag proteins. No viral values were observed at Day 4 when MT4 cells were
cocultured with 6 or 12 days postinfected DC popula-production was detected in infected cultures either by
measurement of RT activity or by using a very sensitive tions. Peak RT activity was detected later (Day 8) when
MT4 cells were cocultured with a 2 day postinfected DCp24 ELISA assay (results not shown). In contrast, as mea-
sured by p24 assay, HIV-1 IIIB-infected unfractionated population. These data indicate that HIV-infected DC do
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FIG. 1. Detection of RT activity in supernatants of HIV-1-infected DC populations cocultured with permissive MT4 cells. MT4 cells were added
to uninfected (*) or to HIV-1-infected DC populations at Days 2 (–m–), 6 (rrlr) or 12 (–j–) postinfection. Supernatants were monitored for RT
activity, as indicated, every 1 or 2 days. Results represent mean values from two independent experiments with SE values of less than 10%. A
statistically significant difference in the time of apparition of RT peak value (Days 4 or 8) was observed between MT4 cocultured with a 2 day- and
MT4 cocultured with a 6- or 12-days postinfected DC.
not release detectable levels of infectious viral particles As evaluated by the examination of ISH slides and a
in the supernatant. However, infectious viral particles are parallel immunoperoxidase staining of samples from the
present in association with DC over a period of at least same DC preparation (Table 2), cell populations are com-
12 days since infection can be transmitted following a posed of approximately 49 and 8% of single cells show-
cell-to-cell contact upon cocultivation of DC with a CD4/ ing, respectively, typical dendritic (HLA-DR/) and thymo-
T cell line. Moreover, the extent of viral transmission by cytic (HLA-DR0) morphology. The remaining cells (43%)
DC seems to correlate with the time of culture postinfec- represent complexes of DC (31%) and thymocytes (12%)
tion, suggesting that viral replication may be an important (DC / T). Surprisingly, cells which were found positive
factor. by ISH, were not randomly distributed among these sub-
sets. At 16 hr postinfection, only cells exhibiting DC mor-
Detection of viral RNA by in situ hybridization phology were found positive by ISH. The proportion of
positive cells among nonthymocyte-associated DC at 16HIV-1-infected DC cultures were analyzed by ISH to
hr postinfection (10.5%) is not statistically different fromdetermine the percentage of cells harboring specific viral
the proportion observed at 48 hr postinfection (9.0%) (PRNAs. No cell labeling was observed in HIV-1 (IIIB)-in-
 0.617). However, the proportion of ISH-positive DCfected DC collected immediately after the adsorption pe-
present in DC / T complexes at 48 hr postinfectionriod (Table 2), indicating that genomic RNAs from virions
(17.0%) is significantly higher than the proportion ob-still present at the cell surface were not detected in our
served at 16 hr postinfection (7.5%) (P  0.0038). More-ISH conditions. However, as shown in Fig. 2c and Table
over, at 48 hr postinfection, nonthymocyte-associated DC2, a total of 18% of cells in the DC population collected 16
which composed the majority of cells in the DC popula-hr postinfection were labeled with the antisense probe. In
tion (49/80: 61%) represented only 34.6% (9/26) of the ISH-contrast, no signal was detected in HIV-1-infected DC
positive DC. In addition, cells with thymocyte morphologypopulations hybridized with the sense probe (Fig. 2a).
were only found positive in DC / T complexes and wereSimilarly, no silver grains were observed in uninfected
only detected at 48 hr postinfection. The mean numberDC populations hybridized with either the antisense (Fig.
of silver grains (from 8 to 15 grains) in thymocytes was2b) or the sense probe (data not shown). Interestingly,
smaller than in DC within these complexes (15 grains).a statistically significant increase in the proportion of
The non-DC-conjugated thymocytes, which represent 8%positively labeled HLA-DR/ cells was observed between
of total cells in our DC preparation, were all found nega-16 and 48 hr postinfection (18 vs 30.5%) (P  0.0035)
(Table 2). tive.
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TABLE 2
Distribution of in Situ Hybridization-Positive Cells among HIV-1-Infected DC Populations
Percentage of cells associated with silver grainsc
(mean of silver grains per cells)d
Distribution of cells
among DC population After 16 hr 48 hr
Cell morphologya (%)b adsorptione postinfectione postinfectione
DC only 49 1 10.5 (/) 9.0 (//)
DC in DC/T complexes 31 1 7.5 (//) 17.0 (///)
T in DC/T complexes 12 1 1 4.5 (//)
T only 8 1 1 1
Total 100 1 18.0 30.5
a Cells exhibiting dendritic (DC) or thymocytic (T) morphology either as single cells or in mixed cell complexes (DC/T). Fixed cells from DC
population were also analyzed by immunocytochemical staining for the presence of HLA-DR antigens. Almost all cells that exhibited a DC morphology
were positive for HLA-DR antigen.
b Mean distribution of cells from two independent experiments based on 200 cells.
c Mean percentage of positive cells from two independent experiments based on 200 cells.
d /, 1 to 7 silver grains; //, 8 to 15 silver grains; ///, more than 15 silver grains per cell.
e Freshly purified cells were infected with HIV-1 and subjected to ISH analysis immediately after the adsorption step or at the indicated time
postinfection.
In conclusion, the enhancement of ISH signal ob- from the presence of a soluble cellular- or viral-derived
toxic product in supernatants.served from 16 to 48 hr postinfection suggests that viral
gene expression occurs in DC culture. Moreover, this Uninfected cells or cells infected with live or heat-inacti-
vated HIV-1 IIIB were examined by electron microscopyanalysis indicates that, after 48 hr postinfection, HIV posi-
tive cells are significantly associated with complexes of from Day 0 to Day 6. As previously described, the majority
of cells in freshly purified population exhibit a typical DCDC and thymocytes.
morphology (Beaulieu et al., 1995). No viral budding could
be detected at the surface of HIV-infected DC.HIV induces cell morphology changes and mortality in
EM analysis also revealed a marked morphologicaldendritic cells
change in cells present in the HIV-1-infected DC culture
To determine the cytopathic potential of HIV-1 on DC, as compared to cells in uninfected or in cultures infected
we performed cell viability and ultrastructural morpholog- with heat-inactivated HIV-1. At each time point following
ical analyses on infected DC. Figure 3 shows that 65% the adsorption period, the proportion of cells showing
of the initial cell number was present in both uninfected vacuolization in HIV-1-infected DC was significantly
and heat-inactivated DC populations after 11 days of cul- higher than in uninfected or in heat-inactivated HIV-1-
ture as evaluated by trypan blue exclusion cell counts. infected DC (all P values of less than 0.001). At 40 hr
In contrast, rapid cell death was observed in DC infected postinfection, 20% of cells showed the presence of cyto-
with both IIIB (Fig. 3) and BaL HIV-1 strains (data not plasmic vacuolization (Fig. 4 and Table 3). The percent-
shown). By Day 3, only 60% of the initial cell number age of cells showing vacuolization as well as the size
remained viable in infected DC cultures compared to 85% and number of these vacuoles increased progressively
in uninfected DC or in heat-inactivated virus-treated DC throughout the infection (Figs. 4c to 4f). At Day 6, approxi-
cultures. Between Days 0 and 3, the calculated mortality mately 50% of cells showed the presence of vacuoles
rate in infected DC was 2.8-fold higher than in the nonin- and approximately 70% of these cells contained vacuoles
fected DC cultures. After 11 days, only 40% of cells re- which occupied almost all the cytoplasmic area (Fig. 4f).
mained viable in HIV-1-infected-DC populations. These In uninfected or heat-inactivated HIV-1-infected DC at
data demonstrate that the presence of HIV-1 induces Day 6 of culture, for example, only approximately 10% of
cytopathic effects in DC cultured in vitro. To determine cells exhibited vacuolization and all vacuoles were of
if the cytopathic effects were due to the presence of a small size. Taken together, these data show that even in
toxic compound in cell supernatants, we added superna- the absence of detectable viral production, the presence
tants collected from HIV-1-infected DC to uninfected DC. of HIV-1 induces cell death and profound morphological
The addition of supernatants collected at Days 1 or 6 changes that could be causally related to cell death.
from uninfected (not shown) or from HIV-1-infected DC
Effect of HIV infection on DC accessory functiondid not significantly increase the mortality of uninfected
DC (Fig. 3). These results indicate that the cytopathicity In vitro studies have demonstrated that human thymic DC
exhibit an efficient accessory function on the proliferation ofobserved in HIV-1-infected DC cultures does not result
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Con A-stimulated mature thymocytes (Beaulieu et al., 1995;
Landry et al., 1990). To further assess the role of thymic DC
in HIV pathogenesis, we studied the ability of in vitro HIV-
1 IIIB-infected DC to function as accessory cells.
FIG. 3. DC survival kinetics. Viable cells were monitored daily by
trypan blue exclusion cell counts. Results represent mean values from
three independent experiments with SE of less than 5%. Statistically
significant differences were observed in the mean values of the number
of cells present in HIV-1 (IIIB)-infected populations (ror) compared to
those in uninfected (*) or in DC treated with heat-inactivated HIV-1
(rnr) or with supernatant collected from autologous HIV-1-infected
DC (rhr) at Day 1 postinfection. Uninfected DC were also treated with
supernatants collected from HIV-1 IIIB- (– r) or heat-inactivated HIV-
1- (– s –) infected allogenic DC at Day 6 postinfection.
As exemplified in Fig. 5A, the [3H]thymidine incorpora-
tion values in the thymocyte proliferation assay using DC
cultured for 24 hr or infected with heat-inactivated virus
ranged from 2,000 to 90,000 cpm with a maximum value
in populations treated with 5 mg/ml of Con A. In contrast
and as observed in 10 independent series of experi-
ments, no significant variation of the thymidine incorpora-
tion from the basal level was observed when 24-hr HIV-1-
infected DC were added to thymocytes in similar assays.
These results indicate that the presence of infectious
HIV-1 completely prevents the effect of DC on the prolifer-
ation of thymocytes.
As previously published (Beaulieu et al., 1995), purified
thymic DC do not represent an homogenous population.
Indeed, a CD4/ cell subset represents approximately
20% of the HLA-DR/ cells. In order to investigate their
eventual role in the apparent lack of thymocyte prolifera-
tion in the DC accessory function assay, we purified in
parallel from the same thymus, DC including HLA-DR//
CD4/ cell subset, and DC mainly depleted of CD4/ cells.
As showed in Fig. 5B, uninfected DC including or not the
CD4/ cell subset induced similar levels of thymocyte
proliferation. No thymidine incorporation was observed
when thymocytes were added to HIV-1-infected DC either
containing the CD4/ DC subset or depleted of it. These
data indicate that accessory function of both DC popula-
tions are similarly affected by the virus, suggesting that
FIG. 2. In situ hybridization of DC populations infected with HIV. Photo- CD4 expression on DC cell surface is not a prerequisite
micrographs show cells from (a) HIV-1-infected DC populations labeled
for the absence of thymocyte proliferation.with control HIV-1 sense probe, (b) uninfected DC populations labeled
As shown in coculture experiments, infected DC werewith antisense HIV-1 probe, and (c) infected DC populations at 2 days
postinfection labeled with anti-sense HIV-1 probe. Magnification 2001. able to transmit HIV to permissive MT4 cells (Fig. 1). Trans-
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FIG. 4. Transmission electron microscopy analysis of HIV-1-infected DC cultures. (a) Uninfected DC (40 hr) and (b) heat-inactivated HIV-1-infected
DC (40 hr) show a normal DC morphology. HIV-1(IIIB)-infected DC show vacuolization (arrows) (40 hr, c; 48 hr, d; Day 4, e; Day 6, f). Magnification:
(a) 5,5301, (b) 6,7201, (c and d) 8,1001, (e) 12,3301 and (f) 4,5601.
mission of HIV-1 from infected DC to thymocytes may inter- Thus direct killing of DC could explain partly the inability of
DC to stimulate thymocyte proliferation in the assays dis-fere with cell proliferation in the DC accessory function
assays. In addition, the presence of HIV-1 was shown to cussed above. In order to determine if such an effect is
mediated by infected cell or by a non-cell-associated fac-promote DC morphological changes and cell killing (Fig. 3).
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TABLE 3
Vacuolization in Uninfected and in HIV-1-Infected DC Populations
Percentage of cells with vacuolesa
(Number of vacuoles per cellb)
[Size of vacuoles]
Time following purificationc
DC population
treatment 0 40 hr 48 hr Day 4 Day 6
Uninfected DC 1 1 1 2 5
(0//) (0//) (/) (/) (/)
DC / HIV-1 1 2 5 5 10
(IIIB) heat-inactivated (0//) (0//) (/) (/) (/)
DC / HIV-1 (IIIB) 1 20 30 35 50
(/) (//) (///) (///) (///)
[small] [small] [small to large] [small to very large] [small to extremely large]
a Mean percentage was calculated from EM observation of at least three independent experiments based on 100 cells.
b Represents the mean number of vacuoles: 0, no vacuole; /, 1 to 10 vacuoles; //, 11 to 30 vacuoles; ///, 30 vacuoles per cell.
c Freshly purified cells were infected as indicated and submitted to EM analysis after the period of adsorption (0) or at the indicated times
postinfection.
tor(s), we collected supernatants at 24 hr from uninfected targeting unfractionated thymocytes, uninfected DC, or
both cell types. For that reason, we monitored using try-DC or from DC infected with heat-inactivated or infectious
HIV-1 IIIB. Filtered cell-free supernatants were used to resus- pan blue exclusion assays, viability of both cell types
treated with supernatants collected from uninfected DC,pend pellet of autologous uninfected 24-hr-purified DC which
were then incubated for an additional 24 hr prior to the or from DC infected with heat-inactivated or IIIB HIV-1
strain at Days 1 and 6 postinfection and/or followingfunctional assay. As exemplified in Fig. 5C, supernatant col-
lected from uninfected DC or from DC infected with heat- purification (Figs. 3 and 6; similar results obtained but
not shown for BaL strain). As previously mentioned, theinactivated HIV-1 do not interfere with the ability of uninfected
DC to stimulate thymocyte thymidine incorporation (maxi- addition of supernatants collected from any of these cul-
tures to uninfected DC did not have significant effect onmum thymidine incorporation values of 78,000 and 84,000
cpm, respectively, in the presence of 2.5 mg/ml of Con A). cell viability (Fig. 3). Surprisingly, the addition of superna-
tants collected either at Day 1 (Fig. 6) or Day 6 (data notHowever, as observed in three independent series of experi-
ments, the addition of supernatant collected from HIV-1-in- shown) from HIV-1-infected DC to unfractionated thymo-
cytes dramatically decreased their viability. In contrast,fected DC in the functional assays interfere with the ability
of uninfected DC to stimulate thymidine incorporation in thy- nontreated unfractionated cells or unfractionated thymic
cells treated with supernatants collected from uninfectedmocyte. As demonstrated above, infectious viral particles
were not present in supernatants collected from HIV-1-in- DC (data not shown) or from DC infected with heat-inacti-
vated virus exhibited similar survival kinetics (Fig. 6).fected DC. These findings indicate that de novo viral infection
of DC or thymocytes in these assays are unlikely to be These data clearly indicate that the absence of thymocyte
proliferation observed upon addition of HIV-1-infectedresponsible for the observed absence of thymocyte prolifera-
tion. In addition, these results indicate that the reduction of DC supernatant results from the killing of thymocytes.
thymocyte proliferation is mediated by one or several soluble
factors present in the supernatant of HIV-1-infected DC. The DISCUSSION
filtered-supernatants collected from HIV-1-infected DC were
In the present study, we investigated the susceptibilityincubated at 587 for 50 min. As presented in Fig. 5C, an
of purified human thymic DC to in vitro HIV-1 infection.increase in the level of thymidine incorporation was ob-
We showed that infectious viral particles were not pres-served when uninfected DC were incubated with heat-
ent in supernatants of HIV-1-infected DC as determinedtreated as compared to non-heat-treated filtered superna-
by the absence of RT activity, p24 antigen detection, andtants collected from infected DC. These data indicate that
reinfection in assays using a highly sensitive HIV-1 per-the factor(s) present in the HIV-1-infected DC supernatant
missive cell line (MT4). Despite the absence of detect-and which affect thymocyte proliferation is heat-labile.
able viral particles in supernatants, thymic DC were
Thymocyte killing factor(s) released from HIV-1- found to be associated with fully infectious HIV-1. The
infected DC presence of infectious particles in infected DC was dem-
onstrated by productive infection of MT4 cells in cocul-The soluble factor(s) present in the HIV-1-infected DC
supernatant may interfere with DC accessory function by ture assays.
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FIG. 6. Unfractionated thymic population survival kinetics. Cell viabil-
ity was monitored daily by trypan blue exclusion. Results represent
mean values from three independent experiments with an SE of less
than 5%. Statistically significant differences were observed in the mean
values of the amount of cells present in unfractionated thymic popula-
tion (rrnr) or in unfractionated thymic population treated with the
Day 1-cultured supernatant collected from autologous DC treated with
heat-inactivated HIV-1 (*) compared to the one collected from HIV-1-
infected DC (–o–).
Thymic DC described in the present paper are com-
posed of 80 to 90% HLA-DR/ cells. As previously re-
ported, the remaining 10 to 20% of cells which are HLA-
DR0 are also negative for several surface markers tested
including CD1a, CD3, CD4, CD8 (Beaulieu et al., 1995).
Among HLA-DR/ cells, different phenotypic subsets were
further defined based, for example, on the expression of
the CD4 receptor. Valentin et al. (1994) have reported
that among triple negative (TN: CD30, CD40, CD80) cell
populations purified from the human thymus, a CD1a/
cell subset, presumably thymic DC, has been reported
to be permissive to HIV-1 infection. Such infection was
reported to be dependent on the presence of very low
levels of CD4 receptor at the cell surface. Our results
clearly demonstrate that DC populations that probably
include similar CD4/ expressing cells do not produce
virions into the supernatants. This indicates that virion
productive cells in the TN cell population reported by
FIG. 5. Evaluation of the accessory function of HIV-1-infected DC Valentin et al. (1994) may not correspond to DC and
and effect of HIV-1-infected DC supernatant on DC accessory function. represents possibly CD30, CD4low/0, CD80 immature thy-
In vitro accessory function was assessed on 24-hr uninfected or HIV- mocytes.
1-infected purified DC in the presence of autologous unfractionated
thymic populations. Accessory activities were evaluated after 72 hr of
stimulation in the presence of the indicated doses of Con A, by labeling
cells with [3H]thymidine for 18 hr. Measurements were made in tripli- hr with filtered supernatants collected from Day 1 cultured uninfected
cate. Histograms represent the level of cell-associated radioactivity or HIV-1 IIIB-infected DC. Accessory activities were measured as de-
following labeling of culture containing (A) the unfractionated thymic scribed above. Histograms represent the level of cell-associated radio-
population alone (j), or cultured in the presence of uninfected DC ( ), activity measured following labeling of culture containing the unfrac-
or of DC infected with heat-inactivated (‰) or live HIV-1 ( ) or (B) the tionated thymic population alone (j) or cultured in the presence of
unfractionated thymic population alone (j), or cultured in the presence autologous purified DC treated with supernatant collected from unin-
of uninfected DC ( ), or of uninfected DC depleted of the CD4 cell fected DC ( ), or from DC infected with heat-inactivated (‰), or with
subset (‰) or in the presence of HIV-1-infected DC ( ), or HIV-1-infected live HIV-1 ( ). Accessory activities were also measured in culture con-
DC depleted of the CD4 cell subset (h). (C) In vitro accessory func- taining uninfected DC incubated with heat-treated supernatant from
tion were performed on uninfected purified DC treated during 24 DC infected with live HIV-1 (h).
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Conflicting data have been reported regarding viral themselves might be rapidly internalized. These hypothe-
sis could provide an explanation for the higher level ofproduction in in vitro HIV-1-infected DC purified from dif-
ferent tissues. However, as DC purification methods ISH signals observed in DC found in complexes com-
pared to those in nonthymocyte-associated DC. More-were improved to eliminate contaminating cells, a new
picture has emerged suggesting that highly purified in- over it could explain the absence of viral particles in
culture supernatants and could also account for the in-fected DC may not efficiently produce viral particles in
supernatants but still can transmit viral infection. Recent creased viral transmission observed with MT4 cocul-
tured with 6- or 12-days postinfected DC compared todata concerning HIV-1 infection of in vitro-purified blood
DC, have shown that these cells do not produce HIV but MT4 cocultured with 2-days postinfected DC.
Our results show that the presence of HIV-1 induceswere reported to be associated with infectious particles
(Cameron et al., 1992). Moreover, a recent report has generalized profound morphological changes and DC
killing. After 6 days of culture, only 50% of the HIV-1-shown that the virus can be efficiently transferred to anti-
gen responding cells although DC need not be infected infected DC remained viable compared to 80% in unin-
fected DC. In addition, half of these cells, compared toto transmit the virus (Cameron et al., 1994). Skin DC,
purified in vitro and shown to be largely free of T cells, 5% among uninfected DC, exhibited abnormal vacuoliza-
tion as observed in EM analysis. The addition of filteredwere recently reported to support viral entry as indicated
by the presence of HIV-1 gag-containing sequences. supernatants collected from DC after 1 or 6 days of HIV-
1 infection did not induce an increase of the cellularHowever, they did not support productive infection as
long as the DC were separated from skin T cells by mortality in uninfected DC cultures. This result indicates
that the induction of cell death observed in HIV-1-infectedsorting (Pope et al., 1994).
Viral replication in thymic DC cultures is indirectly sug- DC cultures is not mediated by soluble cellular- or viral-
derived product(s) but is rather a consequence of DC-gested by results of coculture experiments and ISH anal-
yses. Viral RNAs detected at 16-hr postinfection in HLA- to-virus interaction(s).
Apoptosis is a form of cell death which is important inDR/ cells by ISH analysis may result in part from geno-
mic viral RNAs. However, the number of ISH-positive a wide range of physiological settings and is induced by
diverse stimuli including HIV infection (Vaux, 1993; Reed,cells significantly increased between 16 and 48 hr postin-
fection and moreover at 48 hr postinfection, a larger pro- 1994; and review in Oyaizu and Pahwa, 1995). Apoptosis
of in vitro-purified thymic DC could explain the mortalityportion of HIV-positive cells was found in association
with DC-thymocyte complexes (DC / T). The increase in observed after exposure to HIV-1. However, as observed
by EM, HIV-1-infected DC display ultrastructural charac-the proportion of HIV-positive cells between 16 and 48
hr postinfection may represent the detection of infected teristics which are typical of cell necrosis. Indeed, DC
exhibit distension of mitochondria and organelles andcells having undetectable levels of viral RNA at 16 hr.
Alternatively, but more likely, this increase may reflect an absence of nuclear fragmentation typical of apoptosis.
HIV-1 virions could mediate DC toxicity through interac-viral gene expression and a certain extent of viral spread
among the DC population. We cannot exclude from our tion with the plasma membrane. In this regard, sufficient
level of virus interaction has been shown to result indata that the contaminating immature thymocytes, phe-
notypically CD1a0 TN, might support HIV-1 replication. increased cytoplasmic vacuolization (Fermin and Garry,
1992). Alternatively, DC killing may require the expres-However, the thymocytes which are positive for viral
RNAs are exclusively those which are present in DC / sion of viral gene(s). Additional studies will be necessary
to understand the mechanism of HIV-mediated DC killing.T complexes and are detected only at 48 hr postinfection.
Valentin et al. (1994) have reported that upon HIV-1 infec- We observed that HIV-1 infection of DC in vitro induces
the release of one or several heat-labile soluble factorstion, thymic-purified TN and CD1a/ TN cells readily pro-
duce viral particles into the culture supernatant, whereas in the culture supernatant which mediate the killing of
thymocytes but not DC death. This product could be ac-purified CD1a0 TN cells do not support virus entry. These
findings suggest that in our DC population the presence tively released into the medium as a response to the
interaction of HIV with DC and/or passively released fol-of DC / T complexes might be a prerequisite for the
detection of viral RNA in the TN thymocytes subset. Upon lowing the observed DC death. As demonstrated by ISH
analysis of lymph nodes from HIV-1-infected individuals,interacting with thymic DC, viral particles could replicate
at low levels and/or be transmitted by cell-to-cell contact HIV-1-mediated programmed cell death (PCD) occurs
predominantly in bystander cells and not in productivelyto associated thymocytes. It is interesting to note that
even if viral replication is likely to occur in DC culture, infected cells (Finkel et al., 1995). Moreover, HIV infection
of reconstituted thymus in SCID mice resulted in a rapidno viral particles are detected in the supernatant. A re-
cent study has suggested that in vitro-purified blood DC apoptosis of CD4/ T cells (Aldrovandi et al., 1993; Bony-
hadi et al., 1993). HIV-1 infection of thymic DC in vivomight internalize newly formed virions in a DC-T cell
microenvironment (Cameron et al., 1994). A similar mech- could lead to the release of a killing factor that in turn
could mediate thymocyte PCD.anism may occur in thymic DC, and thus newly formed
virions from DC-associated thymocytes and/or from DC As shown in our ISH analysis, a percentage of HLA-
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